OssDsign AB (publ) (OSSD) Earnings Call Transcripts

OssDsign AB (publ)'s Latest Earnings Call - Q1 FY2026

OssDsign AB reported Q1 2026 revenue of approximately USD 4 million (SEK 36.9 million), marking a 3.6% decline in USD terms and a 17.1% decline in SEK terms compared to Q1 2025. The decline was attributed to currency fluctuations and operational challenges. Adjusted EBIT was reported at minus SEK 13.4 million. Management did not change guidance but reaffirmed their SEK 400 million revenue target for 2026, emphasizing improvements expected in the second half of the year. The stock may be impacted by the revenue shortfall and management's confidence in future growth.

Reported metrics

Guidance from management

Management maintained their SEK 400 million revenue target for 2026, expecting improved commercial momentum in the second half of the year.

What management said

Yes, the 2 new products, which I covered in the comments today, are an MIS product for Catalyst, which is still on track, and we hope to get that out by the end of the year, if not the beginning of 2027. And we are making good progress on the hydrophilic strip product. We are in preclinical right now with a variety of solutions, and that continues to move forward with great progress.

So we started 2025 when the goal was announced, I think, mid-'25 to double the sales force. If you go back and look at what that number was predicated on, I believe, at the beginning of '25, we had 10 direct people in the commercial organization. We will achieve that doubling within Q2. We've had some losses. We've had quite a bit of gains. I'm very impressed by our pace of hiring over the last 90 days. And as far ...

What analysts pressed on

Analysts expressed concerns about the revenue decline, hiring challenges, and the impact of contract renegotiations on sales. They questioned the timeline for new product launches and the potential for further gross margin pressure.

Main topics on the call

• Revenue Decline — Revenue for Q1 2026 decreased by 3.6% in USD terms and 17.1% in SEK terms compared to Q1 2025. Management attributed this to currency fluctuations and operational delays. "This sales outcome really fell short of our expe...
• Operational Challenges — The company faced hiring slowdowns and contract renegotiations that impacted sales growth. "The factors contributing to our first quarter sales challenges are identifiable and addressable," stated Waugh.
• Gross Margin Decline — Gross margin fell to 91.6% from 96.4% in the prior year, influenced by lower sales and negative mix effects. Management noted these effects are temporary.
• Future Growth Initiatives — OssDsign is expanding its U.S. sales force and product portfolio, with two new products in development. "We remain confident of hitting our SEK 400 million revenue target," Waugh reiterated.

Read the full OssDsign AB (publ) transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 18 OssDsign AB (publ) earnings call transcripts on record, spanning February 22, 2022 to August 18, 2026. Based on this history, OssDsign AB (publ) reports quarterly. The most recent call on file is dated August 18, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

OSSD

Exchange

OM

Country

SE

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

18

First call

February 22, 2022

Most recent

August 18, 2026

Reporting cadence

quarterly